BioScience Trends. 2024;18(5):404-408. (DOI: 10.5582/bst.2024.01197)

Strengthening medical facility responses to respiratory infectious diseases: Global trends, challenges, and innovations post-COVID-19

Li XH, Han B, Chen YF, Lu HZ


SUMMARY

Respiratory infectious diseases have long been a serious public health problem. This study explores the significance of respiratory infectious disease prevention and control systems worldwide, particularly during and after the COVID-19 pandemic. The epidemiology of many respiratory diseases such as influenza changed over the past two years, and the incidence of pathogens such as Mycoplasma pneumoniae and Bordetella pertussis has also increased. Based on influenza surveillance data in China, the influenza season in 2023 was notably delayed and extended, with A(H1N1) pdm09 being the predominant strain. This editorial also reviewed the gradual establishment of China's infectious disease prevention and control system following the 2003 SARS outbreak, highlighting the role of medical facilities in managing public health emergencies, conducting infectious disease pre-screening, and reporting cases to networks in real time. In the future, China will further develop an intelligent, multi-trigger infectious disease surveillance and early warning system to increase the early detection of unknown infectious diseases and optimize the allocation of medical resources. A robust infectious disease control system is crucial to addressing future pandemic threats.


KEYWORDS: respiratory infectious disease, influenza, coronavirus disease 2019 (COVID-19), respiratory infectious disease prevention and control system, infectious disease surveillance

Full Text: